Streptococcus salivarius K12
- Reduced Halitosis
- Reduced Acute Otitis Media
- Increased Salivary Streptococcus salivarius K12 Levels
- Increased IL-12 Levels
- Reduced Volatile Sulfur Compounds
- Reduced Frequency of Streptococcal Pharyngeal Infections
- Ensured Safety for Human Consumption
- Reduced Risk of S. pyogenes Infection
- Absence of Treatment-Related Side Effects
- Reduced Biofilm Formation by Candida albicans